Arkolith/Insider Trading/KDNY/Form 4

King Andrew James

Chief Scientific OfficerCHINOOK THERAPEUTICS, INC. (KDNY) · full profile →Form 4 · filed Aug 1, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$46K
Net Open-Market Flow
-$46K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 1, 2023Sell(S)1K$39.03$46K19K
Jul 29, 2023Option exercise(M)3K——20K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 29, 2023Option exercise(M)3K—$07K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-044071) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML